ESC 365 - Proteogenomic analysis in population biobanks identifies new therapeutic targets across heart failure subtypes

ESC Professional Premium Access

Proteogenomic analysis in population biobanks identifies new therapeutic targets across heart failure subtypes

Session: Genetics: new findings across the spectrum of cardiovascular disease

Topic: Drugs, Drug Targets

Speaker: Doctor A. Henry (London, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Albert Henry

University College London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

7 more presentations in this session

Does PhenoAge acceleration impact adverse outcomes following major surgery (rehospitalization or death)? A genome-wide association study and mendelian randomisation

Speaker: Doctor M. Raja (Leicester, GB)

A Genome-Wide Association Study (GWAS) of Takotsubo syndrome

Speaker: Doctor H. Hakansson (Stockholm, SE)

Pathogenic cardiomyopathy gene variants inform prognosis in atrial fibrillation: results from exome sequencing in over 17,000 patients in TIMI trials

Speaker: Mr S. Jurgens (Cambridge, US)

Exome sequencing identifies a novel FBN1 variant in a Chinese family with Marfan syndrome that includes aberrant right subclavian artery

Speaker: Doctor S. Huang (Guangzhou, CN)

Reinterpretation of genetic testing for Cardiomyopathies: Less is more

Speaker: Doctor V. Novelli (Monzino, IT)

Access the full session

Genetics: new findings across the spectrum of cardiovascular disease

Speakers: Doctor A. Henry, Doctor M. Raja, Doctor H. Hakansson, Mr S. Jurgens, Doctor S. Huang...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources